Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 400 participants.
Also called NCT04331769
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Sponsor
- Ancora Heart, Inc.
- Registry
-
NCT04331769
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Belarus, Belgium, Czechia, France, Germany, Greece, Italy, Netherlands, Serbia
- Registry status
- Suspended
Technical summary
Registry record NCT04331769. Randomized; no masking; primary purpose treatment. Start 2020-12-21 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Condition
- Dilated Cardiomyopathy
- Intervention (Device)
- AccuCinch Ventricular Restoration System
- Intervention (Drug)
- Guideline-Directed Medical Therapy
- Lead sponsor
- Ancora Heart, Inc.
Record details
- Record id
cardio:ct-nct04331769- Content hash
f495c5f591d877ec1a96c310078efd45522509b732379d4b0dd35a55c3c23530